---
title: Circulating tumor cell plasticity determines breast cancer therapy resistance
  via neuregulin 1-HER3 signaling
date: '2025-01-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39753722/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250104170649&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Circulating tumor cells (CTCs) drive metastasis, the leading cause of
  death in individuals with breast cancer. Due to their low abundance in the circulation,
  robust CTC expansion protocols are urgently needed to effectively study disease
  progression and therapy responses. Here we present the establishment of long-term
  CTC-derived organoids from female individuals with metastatic breast cancer. Multiomics
  analysis of CTC-derived organoids along with preclinical modeling with xenografts
  ...
disable_comments: true
---
Circulating tumor cells (CTCs) drive metastasis, the leading cause of death in individuals with breast cancer. Due to their low abundance in the circulation, robust CTC expansion protocols are urgently needed to effectively study disease progression and therapy responses. Here we present the establishment of long-term CTC-derived organoids from female individuals with metastatic breast cancer. Multiomics analysis of CTC-derived organoids along with preclinical modeling with xenografts ...